 Drug Costs
"Drug Costs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).
| Descriptor ID |
D016527
|
| MeSH Number(s) |
N03.219.151.400.350 N05.300.375.300
|
| Concept/Terms |
Drug Costs- Drug Costs
- Cost, Drug
- Costs, Drug
- Drug Cost
|
Below are MeSH descriptors whose meaning is more general than "Drug Costs".
Below are MeSH descriptors whose meaning is more specific than "Drug Costs".
This graph shows the total number of publications written about "Drug Costs" by people in this website by year, and whether "Drug Costs" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 | | 1999 | 0 | 2 | 2 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 2 | 3 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 2 | 3 | | 2006 | 1 | 2 | 3 | | 2008 | 1 | 5 | 6 | | 2009 | 0 | 2 | 2 | | 2011 | 0 | 2 | 2 | | 2012 | 1 | 4 | 5 | | 2013 | 0 | 2 | 2 | | 2014 | 3 | 2 | 5 | | 2015 | 0 | 2 | 2 | | 2016 | 3 | 5 | 8 | | 2017 | 4 | 0 | 4 | | 2018 | 0 | 4 | 4 | | 2019 | 3 | 2 | 5 | | 2020 | 4 | 1 | 5 | | 2021 | 3 | 1 | 4 | | 2023 | 1 | 4 | 5 | | 2024 | 1 | 4 | 5 | | 2025 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Costs" by people in Profiles.
-
Lowe EF, Gerasta D, Balser M, Page RL, Tsai E, Biermann HD, Mitchell A, Chan D, Matlock DD, Dickert NW, Sloan CE, Allen LA. Contributors and Solutions to High?Out-of-Pocket Costs for Heart?Failure Medications: A State-of-the-Art Review. J Am Coll Cardiol. 2025 Feb 04; 85(4):365-377.
-
Bradley CJ, Liang R, Lindrooth RC, Sabik LM, Perraillon MC. High-Cost Cancer Drug Use in Medicare Advantage and Traditional Medicare. JAMA Health Forum. 2025 Jan 03; 6(1):e244868.
-
Dickert NW, Speight CD, Balser M, Biermann H, Davis JK, Halpern SD, Ko YA, Krishnan A, Matlock DD, Mitchell AR, Moore MA, Montembeau SC, Morris AA, Noonan K, Rao BR, Scherer LD, Sloan CE, Ubel PA, Allen LA. Integrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF). Circ Cardiovasc Qual Outcomes. 2025 Jan; 18(1):e011273.
-
Jacobs JA, Rodgers A, Bellows BK, Hernandez I, Wang N, Derington CG, King JB, Zheutlin AR, Whelton PK, Egan BM, Cushman WC, Bress AP. Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021. Hypertension. 2024 Nov; 81(11):2307-2317.
-
Anderson KE, Chaiyakunapruk N, Gutierrez EJ, Schmutz HW, Rose MR, Brixner D, McQueen RB. State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization. Health Aff (Millwood). 2024 08; 43(8):1137-1146.
-
Owsley KM, Hasnain-Wynia R, Rooks RN, Tung GJ, Mays GP, Lindrooth RC. US Hospital Service Availability and New 340B Program Participation. JAMA Health Forum. 2024 May 03; 5(5):e240833.
-
Bennett CL, Gibbons JB, Trujillo A, Carson KR, Knopf K, Nabhan C, Rosen ST, Aboulafia DM. Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide. JCO Oncol Pract. 2024 Aug; 20(8):1021-1026.
-
DiStefano MJ, Levy JF, Odouard IC, Anderson GF. Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations. Value Health. 2023 11; 26(11):1618-1624.
-
Anderson KE, DiStefano MJ, Liu A, Mattingly TJ, Socal MP, Anderson GF. Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs. Value Health. 2023 09; 26(9):1381-1388.
-
Owsley KM, Bradley CJ. Access To Oncology Services In Rural Areas: Influence Of The 340B Drug Pricing Program. Health Aff (Millwood). 2023 06; 42(6):785-794.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|